TGFB1 and exocrine pancreatic carcinoma: Activation of T cells followed by addition of TGFβ1 significantly increased adhesion to an E-cadherin transfected pancreatic carcinoma cell line; this treatment had no effect on adhesion to E-cadherin deficient wild-type Panc-1 cells.